|
Q3 2019
Filed on Nov 12, 2019
|
131,573
|
$12.44 - $17.48
$1.64M - $2.3M
|
|
Macquarie Infrastructure Cor
|
Q3 2019
Filed on Nov 12, 2019
|
100,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
262,728
|
$24.09 - $32.18
$6.33M - $8.45M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
809,378
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
14,696
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
29,877
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
6,769,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
197,005
|
$20.0 - $31.88
$3.94M - $6.28M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
204,148
|
$6.42 - $9.0
$1.31M - $1.84M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
15,700
|
$1.95 - $3.93
$30.6K - $61.7K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
98,900
|
N/A
|
|
Protalix Biotherapeutics Inc
|
Q3 2019
Filed on Nov 12, 2019
|
2,631,400
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
7,985
|
$134.24 - $148.53
$1.07M - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
70,088
|
$19.17 - $27.4
$1.34M - $1.92M
|
|
Actinium Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
596,752
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
95,246
|
$7.03 - $9.7
$670K - $924K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
45,700
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
32,000
|
$27.99 - $34.39
$896K - $1.1M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
61,652
|
$32.4 - $49.58
$2M - $3.06M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
22,000
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
144,209
|
$4.6 - $8.46
$663K - $1.22M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
123,954
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
1,960
|
$186.69 - $210.18
$366K - $412K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
92,500
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
181,000
|
$1.2 - $6.66
$217K - $1.21M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
25,837
|
N/A
|
|
Momenta Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
91,462
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
188,982
|
$1.5 - $2.99
$283K - $565K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
3,500
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
108,073
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
47,513
|
$9.41 - $16.56
$447K - $787K
|
|
Portola Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
74,800
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
56,837
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
364,693
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
438,330
|
$1.6 - $2.08
$701K - $912K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
227,383
|
$3.08 - $5.76
$700K - $1.31M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
83,000
|
$42.77 - $50.71
$3.55M - $4.21M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
194,991
|
$8.22 - $11.2
$1.6M - $2.18M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
10,000
|
$26.75 - $31.73
$268K - $317K
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
273,947
|
$7.77 - $11.26
$2.13M - $3.08M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
221,297
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
185,899
|
$16.51 - $23.78
$3.07M - $4.42M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
81,528
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
416,260
|
$8.18 - $11.33
$3.41M - $4.72M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
150,000
|
$15.73 - $41.6
$2.36M - $6.24M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
60,683
|
N/A
|
|
Dicerna Pharmaceuticals Inc
|
Q3 2019
Filed on Nov 12, 2019
|
188,673
|
N/A
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
97,457
|
$7.38 - $12.25
$719K - $1.19M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
148,353
|
$10.82 - $14.25
$1.61M - $2.11M
|
|
|
Q3 2019
Filed on Nov 12, 2019
|
666,589
|
N/A
|
|